A  	A  	 DT	O
study  	study  	 NN	O
of  	of  	 IN	O
implanted  	implanted  	 FW	O
cardiac  	cardiac  	 FW	B-NP
rhythm  	rhythm  	 FW	I-NP
recorders  	recorders  	 FW	I-NP
in  	in  	 FW	O
advanced  	advanced  	 FW	O
cardiac  	cardiac  	 FW	B-NP
AL  	AL  	 FW	O
amyloidosis  	amyloidosis  	 FW	B-NP
AL  	AL  	 FW	O
amyloidosis  	amyloidosis  	 FW	B-NP
may  	may  	 MD	O
respond  	respond  	 VB	O
to  	to  	 TO	O
chemotherapy  	chemotherapy  	 VB	O
but  	but  	 CC	O
two-thirds  	two-thirds  	 NNS	B-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
severe  	severe  	 JJ	O
cardiac  	cardiac  	 JJ	B-NP
involvement  	involvement  	 NN	I-NP
die  	die  	 NN	I-NP
within  	within  	 IN	O
a  	a  	 DT	O
year  	year  	 NN	O
of  	of  	 IN	O
diagnosis 	diagnosis 	 NN	O
,  	,  	 ,	O
purportedly  	purportedly  	 VBG	O
from  	from  	 IN	O
tachyarrhythmias  	tachyarrhythmias  	 NN	B-NP
or  	or  	 CC	O
electromechanical  	electromechanical  	 JJ	B-NP
dissociation 	dissociation 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
sought  	sought  	 VBD	O
to  	to  	 TO	O
characterize  	characterize  	 VB	O
the  	the  	 DT	O
nature  	nature  	 NN	O
of  	of  	 IN	O
cardiac  	cardiac  	 JJ	B-NP
arrhythmias  	arrhythmias  	 NN	I-NP
in  	in  	 IN	O
severe  	severe  	 JJ	O
cardiac  	cardiac  	 JJ	B-NP
AL  	AL  	 NNS	O
amyloidosis  	amyloidosis  	 VBP	O
using  	using  	 VBG	O
implanted  	implanted  	 JJ	O
cardiac  	cardiac  	 JJ	B-NP
rhythm  	rhythm  	 NN	I-NP
recorders 	recorders 	 NNS	I-NP
.  	.  	 .	O
Implantable  	Implantable  	 JJ	B-NP
loop  	loop  	 NN	I-NP
recorders  	recorders  	 NNS	I-NP
( 	( 	 -LRB-	O
ILRs 	ILRs 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
inserted  	inserted  	 VBN	O
within  	within  	 IN	O
24  	24  	 CD	O
h  	h  	 NN	O
of  	of  	 IN	O
baseline  	baseline  	 JJ	B-NP
evaluation  	evaluation  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
UK  	UK  	 NNP	O
National  	National  	 NNP	O
Amyloidosis  	Amyloidosis  	 NNP	O
Centre 	Centre 	 NNP	O
,  	,  	 ,	O
into  	into  	 IN	O
20  	20  	 CD	O
consecutive  	consecutive  	 JJ	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
newly  	newly  	 RB	O
diagnosed  	diagnosed  	 VBN	O
severe  	severe  	 JJ	O
cardiac  	cardiac  	 JJ	B-NP
AL  	AL  	 NNP	O
amyloidosis  	amyloidosis  	 NN	B-NP
and  	and  	 CC	O
symptoms  	symptoms  	 NNS	B-NP
of  	of  	 IN	O
syncope  	syncope  	 NN	O
or  	or  	 CC	O
pre-syncope 	pre-syncope 	 JJ	B-NP
.  	.  	 .	O
Weekly  	Weekly  	 NNP	O
ILR  	ILR  	 NNP	B-NP
recordings  	recordings  	 NNS	I-NP
and  	and  	 CC	O
additional  	additional  	 JJ	O
recordings  	recordings  	 NNS	O
at  	at  	 IN	O
the  	the  	 DT	O
time  	time  	 NN	O
of  	of  	 IN	O
symptoms  	symptoms  	 NNS	B-NP
were  	were  	 VBD	O
obtained 	obtained 	 VBN	O
.  	.  	 .	O
Median  	Median  	 NNP	B-NP
( 	( 	 -LRB-	O
range 	range 	 NN	O
)  	)  	 -RRB-	O
follow-up  	follow-up  	 JJ	O
from  	from  	 IN	O
baseline  	baseline  	 NN	B-NP
was  	was  	 VBD	O
308  	308  	 CD	O
( 	( 	 -LRB-	O
10-399 	10-399 	 NNP	O
)  	)  	 -RRB-	O
days 	days 	 NNS	O
.  	.  	 .	O
Thirteen  	Thirteen  	 JJ	O
patients  	patients  	 NNS	O
died 	died 	 VBD	O
,  	,  	 ,	O
and  	and  	 CC	O
median  	median  	 JJ	B-NP
survival  	survival  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
whole  	whole  	 JJ	O
cohort  	cohort  	 NN	B-NP
was  	was  	 VBD	O
61  	61  	 CD	O
days  	days  	 NNS	O
from  	from  	 IN	O
device  	device  	 NN	B-NP
insertion 	insertion 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
eight  	eight  	 CD	O
evaluable  	evaluable  	 CD	B-NP
cases 	cases 	 NNS	I-NP
,  	,  	 ,	O
death  	death  	 NN	O
was  	was  	 VBD	O
heralded  	heralded  	 VBN	O
by  	by  	 IN	O
bradycardia 	bradycardia 	 NN	B-NP
,  	,  	 ,	O
usually  	usually  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
complete  	complete  	 JJ	B-NP
atrioventricular  	atrioventricular  	 JJ	I-NP
block  	block  	 NN	I-NP
( 	( 	 -LRB-	O
CAVB 	CAVB 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
followed  	followed  	 VBD	O
shortly  	shortly  	 RB	O
thereafter  	thereafter  	 RB	O
by  	by  	 IN	O
pulseless  	pulseless  	 JJ	B-NP
electrical  	electrical  	 JJ	I-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
Four  	Four  	 CD	O
patients  	patients  	 NNS	O
received  	received  	 VBD	O
pacemakers 	pacemakers 	 NNS	O
,  	,  	 ,	O
a  	a  	 DT	O
median  	median  	 JJ	B-NP
( 	( 	 -LRB-	O
range 	range 	 NN	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
7  	7  	 CD	O
( 	( 	 -LRB-	O
3-38 	3-38 	 NNP	O
)  	)  	 -RRB-	O
h  	h  	 NN	O
after  	after  	 IN	O
development  	development  	 NN	O
of  	of  	 IN	O
symptomatic  	symptomatic  	 JJ	B-NP
CAVB 	CAVB 	 NNP	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
these  	these  	 DT	O
did  	did  	 VBD	O
not  	not  	 RB	O
prevent  	prevent  	 VB	O
rapid  	rapid  	 JJ	B-NP
cardiac  	cardiac  	 JJ	I-NP
decompensation  	decompensation  	 NN	I-NP
and  	and  	 CC	O
death  	death  	 NN	O
in  	in  	 IN	O
three  	three  	 CD	O
cases 	cases 	 NNS	O
.  	.  	 .	O
Despite  	Despite  	 IN	O
272  	272  	 CD	O
loop  	loop  	 CD	O
recordings 	recordings 	 NNS	O
,  	,  	 ,	O
there  	there  	 EX	O
was  	was  	 VBD	O
only  	only  	 RB	O
one  	one  	 CD	O
episode  	episode  	 NN	O
of  	of  	 IN	O
non-sustained  	non-sustained  	 JJ	B-NP
ventricular  	ventricular  	 JJ	I-NP
tachycardia 	tachycardia 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
was  	was  	 VBD	O
preceded  	preceded  	 VBN	O
by  	by  	 IN	O
severe  	severe  	 JJ	O
bradycardia 	bradycardia 	 NN	B-NP
.  	.  	 .	O
Patients  	Patients  	 NNS	O
who  	who  	 WP	O
died  	died  	 VBD	O
had  	had  	 VBN	O
significantly  	significantly  	 RB	O
worse  	worse  	 RBR	O
global  	global  	 JJ	O
left  	left  	 JJ	O
ventricular  	ventricular  	 JJ	B-NP
strain  	strain  	 NN	I-NP
on  	on  	 IN	O
echocardiography  	echocardiography  	 NNS	B-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.029 	0.029 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
reduced  	reduced  	 VBD	O
6  	6  	 CD	O
min  	min  	 NNS	B-NP
walk  	walk  	 VBP	O
distance  	distance  	 NN	O
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.048 	0.048 	 CD	O
)  	)  	 -RRB-	O
at  	at  	 IN	O
baseline  	baseline  	 NN	B-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
survivors 	survivors 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
discovery  	discovery  	 NN	O
that  	that  	 WDT	O
bradyarrhythmias  	bradyarrhythmias  	 VBZ	O
heralded  	heralded  	 VBN	O
terminal  	terminal  	 JJ	B-NP
cardiac  	cardiac  	 JJ	I-NP
decompensation  	decompensation  	 NN	I-NP
in  	in  	 IN	O
most  	most  	 JJS	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
severe  	severe  	 JJ	O
cardiac  	cardiac  	 JJ	B-NP
AL  	AL  	 NNP	O
amyloidosis  	amyloidosis  	 NN	B-NP
supports  	supports  	 VBZ	O
a  	a  	 DT	O
study  	study  	 NN	O
of  	of  	 IN	O
prophylactic  	prophylactic  	 JJ	B-NP
pacemaker  	pacemaker  	 NN	I-NP
insertion  	insertion  	 NN	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
patient  	patient  	 JJ	O
population 	population 	 NN	O
.  	.  	 .	O
